Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tandem Diabetes Care, Inc. - Common Stock (NQ: TNDM ) 36.88 -0.49 (-1.31%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Tandem Diabetes Care, Inc. - Common Stock < Previous 1 2 3 4 5 6 Next > Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada December 10, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Announces Upcoming Conference Presentations November 21, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance November 06, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Announces Upcoming Conference Participation October 30, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024 October 02, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union September 19, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Announces Upcoming Conference Participation August 26, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide Recall August 19, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS Devices August 12, 2024 From Tandem Diabetes Care, Inc. Via Business Wire TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm August 09, 2024 From Bragar Eagel & Squire Via GlobeNewswire Tandem Diabetes Care Announces Second Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance August 01, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Announces Upcoming Conference Presentation July 30, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada July 29, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024 July 11, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions June 22, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer June 20, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific Sessions June 18, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM May 29, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Announces Upcoming Conference Presentation May 23, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance May 02, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Announces Upcoming Conference Presentations April 29, 2024 From Tandem Diabetes Care, Inc. Via Business Wire TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm April 23, 2024 From Bragar Eagel & Squire Via GlobeNewswire Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024 April 09, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Parexel Announces CEO Succession Plan March 18, 2024 Chief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald effective May 15, 2024; Mr. Macdonald to retire as CEO and continue on the Board of Directors through Dec. 31, 2024 From Parexel International LLC Via GlobeNewswire Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029 March 06, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes March 04, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Inc. (NASDAQ: TNDM) Making Surprising Moves in Thursday Session February 22, 2024 Via Investor Brand Network Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance February 21, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Launches Tandem Mobi, the World’s Smallest, Durable Automated Insulin Delivery System February 13, 2024 From Tandem Diabetes Care, Inc. Via Business Wire Tandem Diabetes Care Announces Upcoming Conference Presentations February 08, 2024 From Tandem Diabetes Care, Inc. Via Business Wire < Previous 1 2 3 4 5 6 Next > Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
